Topical tacrolimus in alopecia areata.

Abstract

Eleven patients with alopecia areata affecting 10% to 75% of the scalp, average duration 6 years, had no terminal hair growth in response to tacrolimus ointment 0.1% applied twice daily for 24 weeks. Treatment failure may reflect insufficient depth of penetration of the ointment formulation and less than optimal patient selection.

• Authors: Vera H Price, Andrea Willey, Bryan K Chen
• Journal: Journal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 52 Issue 1 Pg. 138-9 (Jan 2005) ISSN: 1097-6787 [Electronic] United States
• PMID: 15627095 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Immunosuppressive Agents
• Ointments
• Tacrolimus

Topics

• Administration, Topical
• Adolescent
• Adult
• Alopecia Areata (drug therapy)
• Female
• Humans
• Immunosuppressive Agents (administration & dosage)
• Male
• Middle Aged
• Ointments
• Tacrolimus (administration & dosage)